Health

How can research stem the tide of the NCD pandemic?

April 11, 2017

Global

April 11, 2017

Global
Glenda Gray

Chair

Glenda Gray trained as a medical doctor and paediatrician at the University of the Witwatersrand in South Africa and co-founded and led the internationally renowned Perinatal HIV Research Unit, based at Chris Hani Baragwanath Hospital in Soweto. Professor Gray is an "A"-rated scientist by the National Research Foundation of South Africa. She has also been awarded the “Hero of Medicine” award by the International Association of Physicians in AIDS Care for work done in the field of HIV treatment in children and adults. Moreover, she is president of the South African Medical Research Council. 

In 2009 Professor Gray and James McIntyre received the N’Galy-Mann lectureship in recognition of their HIV research contribution in South Africa. In June 2012 she received a DSc (honoris causa) from Simon Fraser University, Vancouver, for her work in the field of mother-to--child transmission of HIV. She was admitted into the American Academy of Microbiology in 2012. In 2013 she received South Africa's highest honour, the Order of Mapungubwe, granted by the country's president.

Governments should consider long-term investments in high-quality peer-reviewed implementation research to tackle the growth of non-communicable diseases (NCDs) in developing countries.

Using implementation science, we can find simple, cost-effective ways of redesigning health systems to suit our population’s needs. This in turn, will contribute to easing the global burden of non-communicable diseases (NCDs), which has just been highlighted again by research from The Economist Intelligence Unit, .

Knowledge sharing

Sharing of knowledge and research developments is crucial in the quest to find appropriate solutions to the NCD crisis. In a playground in a primary school in Changzhi in northern China, 11 year-olds have been learning about the health benefits of reducing the amount of salt used at home. A between UK- and China-based universities has been empowering children to educate their families. In India, joint research teams from Hyderabad, Delhi, Gurgaon and Sydney, Australia, have been looking at how to develop the evidence base for a , using population, stakeholder and food surveys. Teams like these meet annually under the umbrella of the Global Alliance for Chronic Diseases (GACD) and share strategies, whilst contributing to global working groups across a spectrum of interventions.

Governments can take the evidence forward from this global approach to NCD research by using the evidence to implement programmes at scale. A signed between the GACD and the World Bank Group will see China working with international research teams using an implementation science approach to take their hypertension prevention and management programmes to scale. The intent of this World Bank-GACD collaboration is to integrate implementation research into large-scale health systems reforms, which aim to achieve universal access to simple solutions to combat the rising tide of NCDs. The initial focus of the partnership will be on the prevention and control of hypertension in two districts in China.

China’s experience mirrors the NCD story in upper middle-income countries, with an estimated 82% of the country’s disease burden . With high levels of salt intake and tobacco use, incidence rates for heart attack and stroke are very high. Additional NCD risk factors such as lack of exercise and excessive alcohol consumption can also have damaging effects in developing-country settings. Many developing countries just do not have the infrastructure and resources to cope with the rise in NCDs. For example, in Sub-Saharan Africa (excluding South Africa), not a single country has more than one (by contrast, in North America, there are ten machines per 1m).

Practical solutions

Solutions to these health challenges can come from innovative implementation research, which generates context-specific evidence, so that governments have the data to bridge this gap effectively. The more countries invest in joint research partnerships, the more we might begin to learn from multidirectional innovations. Low- and middle-income countries can thus build valuable partnerships with middle- and high-income countries, while benefiting from knowledge sharing about cost-effective practical solutions to wider NCD and global health problems.

 

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of The Economist Intelligence Unit Limited (EIU) or any other member of The Economist Group. The Economist Group (including the EIU) cannot accept any responsibility or liability for reliance by any person on this article or any of the information, opinions or conclusions set out in the article.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week